|
WO2021058145A1
|
|
Phage t7 promoters for boosting in vitro transcription
|
|
WO2020193628A1
|
|
Enhancement of cytolytic t-cell activity by inhibiting ebag9
|
|
EP3786178A1
|
|
Tcr constructs specific for ebv-derived antigens
|
|
WO2020030687A1
|
|
A fret-based method to measure seeding activity of misfolded protein species in biological samples
|
|
WO2020016327A1
|
|
Method for analyzing cell sample heterogeneity
|
|
EP3760217A1
|
|
Cd5 specific t cell receptor cell or gene therapy
|
|
US2021061876A1
|
|
T cell receptors for tumor specific proteasome splice variants and uses thereof
|
|
WO2019122302A1
|
|
Nucleic acid sequence replacement by nhej
|
|
EP3670530A1
|
|
Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies
|
|
EP3551183A1
|
|
Inhibitors of mechanotransduction to treat pain and modulate touch perception
|
|
EP3474060A1
|
|
Autofocus-control of a microscope including an electrically tunable lens
|
|
WO2018033544A1
|
|
Method for the generation of t cell hybridoma for cloning and analysis of receptors using engineered measles virus fusogenic glycoproteins
|
|
EP3354658A1
|
|
Novel t cell receptors and immune therapy using the same for the treatment of cancer and infectious diseases
|
|
EP3321264A1
|
|
Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways
|
|
EP3230465A1
|
|
Genome architecture mapping
|
|
EP3189141A1
|
|
Antisense oligonucleotides targeting 3'utr region of a20
|
|
EP2919009A1
|
|
LRRC8 proteins and protein complexes and methods for identification of channel modulators
|
